Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 6Genitourinary 6Gastrointestinal 6CNS 3Thoracic 2Sarcoma 2Lymphoid 2Gynecologic 2Other 1Head & Neck 1Breast 1

Conditions

Uterine Cervical Neoplasms 28Endometrial Neoplasms 9Vaginal Neoplasms 5Ovarian Neoplasms 5Vulvar Neoplasms 3Fallopian Tube Neoplasms 3Esophageal Neoplasms 3Endometrial Clear Cell Adenocarcinoma 3Uterine Neoplasms 2Sarcoma 2Prostatic Neoplasms 2Neoplasms 2Melanoma 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Sarcoma, Synovial 1Peritoneal Neoplasms 1Pelvic Inflammatory Disease 1Patient Compliance 1Neoplasm Metastasis 1Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified 1Locally Advanced Cervical Carcinoma 1Locally Advanced Cervical Adenocarcinoma 1Liposarcoma, Myxoid 1Hyperthermia 1Head and Neck Neoplasms 1HIV Infections 1Endometriosis 1Endometrial Adenocarcinoma 1Diarrhea 1

Interventions

Paclitaxel 28Carboplatin 28pembrolizumab 25Bevacizumab 14liposomal doxorubicin 12Cisplatin 11Gemcitabine 10Radiotherapy 8Drug Therapy 8Cyclophosphamide 8Blood Specimen Collection 8Topotecan 7Nivolumab 7olaparib 6Doxorubicin 6niraparib 5Therapeutics 5Dexamethasone 5pertuzumab 4pazopanib 4lenvatinib 4fludarabine 4cemiplimab 4atezolizumab 4Trastuzumab 4Surveys and Questionnaires 4Psychiatric Rehabilitation 4Polymerase Chain Reaction 4Fulvestrant 4Docetaxel 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms × Radiation × Gynecologic × Clear all
NCT00924027 2025-09-05

A Study of Patients Receiving High-Dose Rate Brachytherapy

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
43 enrolled 13 charts
GastrointestinalGenitourinaryGynecologic

Biliary Tract Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

NCT00510250 2015-07-27

A Phase I/II Study of Cisplatin and Radiation in Combination With Sorafenib in Cervical Cancer

University Health Network, Toronto

Phase 1/2 Completed
13 enrolled
Gynecologic

Carcinoma, Uterine Cervical Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡